Xiaoping Liao

Mar 20, 2024 | mdpi.com | Xiaoping Liao |Juan Lu |Junyan Ma |Yeda Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jun 10, 2023 | onlinelibrary.wiley.com | jingyi Cai |Xiaoping Liao |Haihe Laboratory |Yufeng Mao

Recent advances in biofoundries have enabled the construction of a large quantity of strains in parallel, accelerating the Design-Build-Test-Learn (DBTL) cycles for strain development. However, the construction of a large number of strains by iterative gene manipulation is still time-consuming and costly, posing a challenge for the development of commercial strains.